Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years
Clinical trial NCT07428759 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07428759
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-10
- Primary completion
- 2026-12-09
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.